The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study

SIMPLE SUMMARY: Radium-223 is an alpha-emitting radioisotope that selectively binds to increased bone turnover areas, such as metastatic sites, acting as a bone-seeking calcium mimetic drug. Its therapeutic function in metastatic castration-resistant prostate cancer patients relies on its capability...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauckneht, Matteo, Rebuzzi, Sara Elena, Signori, Alessio, Donegani, Maria Isabella, Murianni, Veronica, Miceli, Alberto, Borea, Roberto, Raffa, Stefano, Damassi, Alessandra, Ponzano, Marta, Catalano, Fabio, Martelli, Valentino, Marini, Cecilia, Boccardo, Francesco, Morbelli, Silvia, Sambuceti, Gianmario, Fornarini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693606/
https://www.ncbi.nlm.nih.gov/pubmed/33142739
http://dx.doi.org/10.3390/cancers12113213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693606/
https://www.ncbi.nlm.nih.gov/pubmed/33142739
http://dx.doi.org/10.3390/cancers12113213

Ejemplares similares